Статья
Основные положенияПредставлен анализ современных литературных данных, посвященных доказательной базе применения методов внутрисосудистой визуализации у пациентов с поражениями «незащищенного» ствола левой коронарной артерии. РезюмеЧрескожное коронарное вмешательство представляет собой альтернативу коронарному шунтированию при лечении поражений ствола левой коронарной артерии у пациентов с ишемической болезнью сердца. Стентирование ствола левой коронарной артерии под контролем внутрисосудистой ультразвуковой визуализации и оптической когерентной томографии улучшает госпитальные и отдаленные результаты вмешательства. Однако до сих пор остается открытым вопрос о выборе метода визуализации в данной группе больных.
1. Nowbar A.N., Gitto M., Howard J.P., Francis D.P., Al-Lamee R. Mortality From Ischemic Heart Disease. Circ Cardiovasc Qual Outcomes2019;12(6):e005375. doi: 10.1161/CIRCOUTCOMES.118.005375.
2. Virani S.S., Alonso A., Benjamin E.J., Bittencourt M.S., Callaway C.W., Carson A.P., Chamberlain A.M., Chang A.R., et al.. Heart disease and stroke statistics: 2020 update—a report from the American Heart Association.Circulation 2020;141(9):e139–e596. doi: 10.1161/CIR.0000000000000757.
3. Neumann F.J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A.P., Benedetto U., Byrne R.A., Collet J.P., et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394.
4. Yager N., Schulman-Marcus J., Torosoff M. Coronary anatomy and comorbidities impact on elective PCI outcomes in left main and multivessel coronary artery disease. Catheter Cardiovasc Interv. 2021;98(3):436-444. doi:10.1002/ccd.29368
5. Бокерия Л.А., Алекян Б.Г., Коломбо А., Бузиашвили Ю.И. Интервенционные методы лечения ишемической болезни сердца: рук. для врачей. М: Изд-во НЦССХ им. А.Н. Бакулева РАМН, 2002. 314–321.
6. O'Keefe J.H. Jr., Hartzler G.O., Rutherford B.D., McConahay D.R., Johnson W.L., Giorgi L.V., Ligon R.W. Left main coronary angioplasty: early and late results of 127 acute and elective procedures. Am J Cardiol. 1989;64(3):144-7. doi: 10.1016/0002-9149(89)90447-5.
7. Karam C., Jordan C., Fajadet J. et al. Six-mounth follow-up of unprotected left main coronary artery stenting. Circulation. 1996; 94( Suppl 1): 627.
8. Patel M. R., Dehmer G. J., Hirshfeld J. W., Smith P. K., Spertus J. A., American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, Heart Failure Society of America, & Society of Cardiovascular Computed Tomography ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. JACC. 2009;53 (6): 530–553. doi:10.1016/j.jacc.2008.10.005
9. Valgimigli M., van Mieghem C.A., Ong A.T., Aoki J., Granillo G.A., McFadden E.P., Kappetein A.P., de Feyter P.J., et al. Short-and long- term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital Registries (RESEARCH and T- SEARCH). Circulation. 2005;111(11):1383-9. doi: 10.1161/01.CIR.0000158486.20865.8B.
10. Valgimigli M., Malagutti P., Rodriguez-Granillo G.A., Garcia-Garcia H.M., Polad J., Tsuchida K., Regar E., Van der Giessen W.J., et al. Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug- eluting stent era: an integrated clinical and angiographic analysis based on the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) registries. J. Am. Coll. Cardiol. 2006;47(8):1530-7. doi: 10.1016/j.jacc.2005.11.066.
11. Зырянов И.П., Кузнецов В.А., Бессонов И.С. и др. Особенности коронарного стентирования у пациентов с поражением ствола левой коронарной артерии. Патология кровообращения и кардиохирургия. 2009; 4: 54–57.
12. Erglis A., Narbute I., Kumsars I., Jegere S., Mintale I., Zakke I., Strazdins U., Saltups A. A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis. J Am Coll Cardiol. 2007;50(6):491-7. doi: 10.1016/j.jacc.2007.03.055.
13. Meliga E., Garcia-Garcia H.M., Valgimigli M., Chieffo A., Biondi-Zoccai G., Maree A.O., Cook S., Reardon L., et al. ; DELFT (Drug Eluting stent for LeFT main) Registry. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry. J Am Coll Cardiol. 2008;51(23):2212-9. doi: 10.1016/j.jacc.2008.03.020.
14. Алекян Б.Г., Григорьян А.М., Стаферов А.В., Кавтеладзе З.А., Скрыпник Д.В., Тарасов Р.С. Рентгенэндоваскулярная диагностика и лечение заболеваний сердца и сосудов в Российской Федерации – 2023 год. Эндоваскулярная хирургия. 2024; 11 (Специальный выпуск): S1–S300.
15. Topol T.J., Nissen S.E. Our preoccupation with coronary lumenology: the dissociation between clinical and angiographic findings in ischemic heart disease. Circulation 1995; 92:2333-2342.
16. Nissen S.E., Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation 2001; 103:604-616.
17. Mintz G.S., Nissen S.E., Anderson W.D., Bailey S.R., Erbel R., Fitzgerald P.J., Pinto F.J., Rosenfield K., et al. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). J Am Coll Cardiol 2001; 37:1478-1492. doi: 10.1016/s0735-1097(01)01175-5.
18. Di Mario C., Gorge G., Peters R., Kearney P., Pinto F., Hausmann D., von Birgelen C., Colombo A., et al. Clinical application and image interpretation in intracoronary ultrasound. Europ Heart J 1998; 19:207-219. doi: 10.1053/euhj.1996.0433.
19. Fajadet J., Chieffo A. Current management of left main coronary artery disease. Eur Heart J. 2012;33(1):36-50b. doi: 10.1093/eurheartj/ehr426.
20. Рентгенэндоваскулярная хирургия. Национальное Руководство: в 2т. Т.3 Ишемическая болезнь сердца / под ред. академика Алекяна Б.Г. М. : Литерра, 2017. 137.
21. Authors/Task Force members, Windecker, S., Kolh, P., Alfonso, F., Collet, J. P., Cremer, J., Falk, V., et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014 Oct 1;35(37):2541-619. doi: 10.1093/eurheartj/ehu278.
22. Panuccio, G., Abdelwahed, Y. S., Carabetta, N., Salerno, N., Leistner, D. M., Landmesser, U., De Rosa, S., Torella, D., Werner, G. S. Clinical and Procedural Outcomes of IVUS-Guided vs. Angiography-Guided CTO-PCI: A Systematic Review and Meta-Analysis. Journal of clinical medicine. 2023; 12(15): 4947. doi:10.3390/jcm12154947.
23. Neumann F.J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A.P., Benedetto U., Byrne R.A., Collet J.P., et al.; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87-165. doi: 10.1093/eurheartj/ehy394.
24. Vrints C., Andreotti F., Koskinas K. C., Rossello X., Adamo M., Ainslie J., Banning A. P., Budaj A. et al.; ESC Scientific Document Group (2024). 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415-3537. doi: 10.1093/eurheartj/ehae177.
25. Panuccio G., Abdelwahed Y.S., Carabetta N., Salerno N., Leistner D.M., Landmesser U., De Rosa S., Torella D., Werner G.S. Clinical and Procedural Outcomes of IVUS-Guided vs. Angiography-Guided CTO-PCI: A Systematic Review and Meta-Analysis. J Clin Med. 2023;12(15):4947. doi: 10.3390/jcm12154947.
26. Groenland F.T.W., Neleman T., Kakar H., Scoccia A., Ziedses des Plantes A.C., Clephas P.R.D., Chatterjee S., et al. Intravascular ultrasound-guided versus coronary angiography-guided percutaneous coronary intervention in patients with acute myocardial infarction: A systematic review and meta-analysis. Int J Cardiol. 2022;353:35-42. doi: 10.1016/j.ijcard.2022.01.021.
27. Pang J., Ye L., Chen Q. How to guide PCI?: A network meta-analysis. Medicine (Baltimore). 2020;99(20):e20168. doi: 10.1097/MD.0000000000020168.
28. Zhang J., Gao X., Kan J., Ge Z., Han L., Lu S., Tian N., Lin S., et al. Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: The ULTIMATE Trial. J Am Coll Cardiol. 2018;72(24):3126-3137. doi:10.1016/j.jacc.2018.09.013
29. Park D.Y., An S., Jolly N., Attanasio S., Yadav N., Gutierrez J.A., Nanna M.G., Rao S.V., Vij A. Comparison of intravascular ultrasound, optical coherence tomography, and conventional angiography-guided percutaneous coronary interventions: A systematic review, network meta-analysis, and meta-regression. Catheter Cardiovasc Interv. 2023;102(3):440-450. doi: 10.1002/ccd.30784.
30. Choi K.H., Song Y.B., Lee J.M., Lee S.Y., Park T.K., Yang J.H., Choi J.H., Choi S.H., Gwon H.C., Hahn J.Y. Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing Complex Procedures. JACC Cardiovasc Interv. 2019;12(7):607-620. doi: 10.1016/j.jcin.2019.01.227.
31. Wang Y., Mintz G.S., Gu Z., Qi Y., Wang Y., Liu M., Wu X. Meta-analysis and systematic review of intravascular ultrasound versus angiography-guided drug eluting stent implantation in left main coronary disease in 4592 patients. BMC Cardiovasc Disord. 2018;18(1):115. doi: 10.1186/s12872-018-0843-z.
32. Fassa A.A., Wagatsuma K., Higano S.T., Mathew V., Barsness G.W., Lennon R.J., Holmes D.R. Jr., Lerman A. Intravascular ultrasound-guided treatment for angiographically indeterminate left main coronary artery disease: a long-term follow-up study. J Am Coll Cardiol. 2005;45(2):204-11. doi: 10.1016/j.jacc.2004.09.066.
33. Park S.J., Ahn J.M., Kang S.J., Yoon S.H., Koo B.K., Lee J.Y., Kim W.J., et al. Intravascular ultrasound-derived minimal lumen area criteria for functionally significant left main coronary artery stenosis. JACC Cardiovasc Interv 2014;7:868–874. doi: 10.1016/j.jcin.2014.02.015.
34. de la Torre Hernandez J.M., Hernandez Hernandez F., Alfonso F., Rumoroso J.R., Lopez-Palop R., Sadaba M., Carrillo P., Rondan J., et al.; LITRO Study Group. Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study. J Am Coll Cardiol 2011; 58:351–358. doi: 10.1016/j.jacc.2011.02.064.
35. Барбараш О.Л., Карпов Ю.А., Панов А.В., Акчурин Р.С., Алекян Б.Г., Алехин М.Н., Аронов Д.М., Арутюнян Г.К., и др. Стабильная ишемическая болезнь сердца. Клинические рекомендации 2024. Российский кардиологический журнал. 2024;29(9):6110. doi:10.15829/1560-4071-2024-6110.
36. de la Torre Hernandez J.M., Garcia Camarero T., Baz Alonso J.A., Gómez-Hospital J.A., Veiga Fernandez G., Lee Hwang D.H., Sainz Laso F., Sánchez-Recalde Á., et al. Outcomes of predefined optimisation criteria for intravascular ultrasound guidance of left main stenting. EuroIntervention. 2020; 16: 210-217. doi: 10.4244/EIJ-D-19-01057.
37. Kim J.H., Kang D.Y., Ahn J.M., Kweon J., Choi Y., Kim H., Lee J., Chae J., et al. Optimal Minimal Stent Area and Impact of Stent Underexpansion in Left Main Up-Front 2-Stent Strategy. Circ Cardiovasc Interv. 2024;17(1):e013006. doi: 10.1161/CIRCINTERVENTIONS.123.013006.
38. Рентгенэндоваскулярная хирургия. Национальное Руководство: в 2т. Т.3 Ишемическая болезнь сердца / под ред. Академика Алекяна Б.Г. М. : Литерра, 2017.
39. Bouma B.E., Tearney G.J., Yabushita H., Shishkov M., Kauffman C.R., DeJoseph Gauthier D., MacNeill B.D., Houser S.L., Aretz H.T., Halpern E.F., Jang I.K. Evaluation of intracoronary stenting by intravascular optical coherence tomography. Heart. 2003;89(3):317-20. doi: 10.1136/heart.89.3.317.
40. Gonzalo N., Serruys P.W., Okamura T., Shen Z.J., Onuma Y., Garcia-Garcia H.M., Sarno G., Schultz C., et al. Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: a systematic quantitative approach. Heart. 2009;95(23):1913-9. doi: 10.1136/hrt.2009.172072.
41. Dato I., Burzotta F., Trani C., Romano A., Porto I., Aurigemma C., Niccoli G., Leone A.M., Crea F. Angiographically intermediate left main bifurcation disease assessment by frequency domain optical coherence tomography (FD-OCT). Int J Cardiol. 2016;220:726-8. doi: 10.1016/j.ijcard.2016.06.260.
42. Cortese B., Burzotta F., Alfonso F., Pellegrini D., Trani C., Aurigemma C., Rivero F., Antuña P., Orrego P.S., Prati F. Role of optical coherence tomography for distal left main stem angioplasty. Catheter Cardiovasc Interv. 2020;96(4):755-761. doi: 10.1002/ccd.28547.
43. Cortese B., de la Torre Hernandez J.M., Lanocha M., Ielasi A., Giannini F., Campo G., D'Ascenzo F., Latini R.A., et al. Optical coherence tomography, intravascular ultrasound or angiography guidance for distal left main coronary stenting. The ROCK cohort II study. Catheter Cardiovasc Interv. 2022;99(3):664-673. doi: 10.1002/ccd.29959.
44. Fazel R., Yeh R.W., Cohen D.J., Rao S.V., Li S., Song Y., Secemsky E.A. Intravascular imaging during percutaneous coronary intervention: temporal trends and clinical outcomes in the USA. Eur Heart J. 2023;44(38):3845-3855. doi: 10.1093/eurheartj/ehad430.
45. Алекян Б.Г., Григорьян А.М., Стаферов А.В., Карапетян Н.Г. Рентгенэндоваскулярная диагностика и лечение заболеваний сердца и сосудов в Российской Федерации – 2023 год. Эндоваскулярная хирургия.2022; (Специальный выпуск).